佛慈制药：9月28日召开董事会会议

Group 1 - The core point of the article is that 佛慈制药 (Foci Pharmaceutical) held its eighth board meeting on September 28, 2025, to discuss various proposals, including providing guarantees for its wholly-owned subsidiary [1] - For the first half of 2025, 佛慈制药's revenue composition was 99.89% from the pharmaceutical industry and 0.11% from the food industry [1] - As of the time of reporting, 佛慈制药's market capitalization was 4.4 billion yuan [1]